| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.005 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.005 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.005 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.006 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.086 | 0.007 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.007 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.082 | 0.007 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.008 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |